Addressing the Gap in Keratoconus Diagnosis

Clinical Report: Addressing the Gap in Keratoconus Diagnosis

Overview

Keratoconus (KC) is often diagnosed at advanced stages, leading to significant vision loss. Early screening is crucial for timely intervention.

Background

Keratoconus is classified as a rare disease under the Orphan Drug Act, yet its prevalence may be underestimated. Early diagnosis is critical, as many patients are diagnosed only after the disease has progressed significantly.

Data Highlights

No numerical data available in the source material.

Key Findings

Approximately 70% of keratoconus patients are diagnosed at moderate to advanced stages.
Only about 12% of newly diagnosed patients receive cross-linking therapy.
Topography/tomography is the most effective method for early detection of keratoconus.
Patients with certain conditions, such as Down syndrome and sleep apnea, have an elevated risk for keratoconus.

Clinical Implications

Healthcare providers should be aware of the importance of early screening for keratoconus in high-risk populations.

Conclusion

Addressing the gaps in keratoconus diagnosis through early screening can help in timely intervention.

PentaVision

Optometric Management